Adrenal Dysfunction in Mitochondrial Diseases

Cortisol is central to several homeostatic mechanisms including the stress and immune response. Adrenal insufficiency and impaired cortisol production leads to severe, potentially fatal disorders. Several fundamental stages of steroidogenesis occur within the mitochondria. These dynamic organelles n...

Full description

Bibliographic Details
Main Authors: Madeleine Corkery-Hayward, Louise A. Metherell
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/2/1126
_version_ 1797441525769043968
author Madeleine Corkery-Hayward
Louise A. Metherell
author_facet Madeleine Corkery-Hayward
Louise A. Metherell
author_sort Madeleine Corkery-Hayward
collection DOAJ
description Cortisol is central to several homeostatic mechanisms including the stress and immune response. Adrenal insufficiency and impaired cortisol production leads to severe, potentially fatal disorders. Several fundamental stages of steroidogenesis occur within the mitochondria. These dynamic organelles not only contribute ATP for steroidogenesis, but also detoxify harmful by-products generated during cortisol synthesis (reactive oxygen species). Mutations in nuclear or mitochondrial DNA that impair mitochondrial function lead to debilitating multi-system diseases. Recently, genetic variants that impair mitochondrial function have been identified in people with isolated cortisol insufficiency. This review aimed to clarify the association between mitochondrial diseases and adrenal insufficiency to produce cortisol. Mitochondrial diseases are rare and mitochondrial diseases that feature adrenal insufficiency are even rarer. We identified only 14 cases of adrenal insufficiency in people with confirmed mitochondrial diseases globally. In line with previous reviews, adrenal dysfunction was most prevalent in mitochondrial deletion syndromes (particularly Pearson syndrome and Kearns–Sayre syndrome) and with point mutations that compromised oxidative phosphorylation. Although adrenal insufficiency has been reported with mitochondrial diseases, the incidence reflects that expected in the general population. Thus, it is unlikely that mitochondrial mutations alone are responsible for an insufficiency to produce cortisol. More research is needed into the pathogenesis of adrenal disease in these individuals.
first_indexed 2024-03-09T12:25:23Z
format Article
id doaj.art-01bf044067c142a9abd211209c1d88fe
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T12:25:23Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-01bf044067c142a9abd211209c1d88fe2023-11-30T22:35:46ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01242112610.3390/ijms24021126Adrenal Dysfunction in Mitochondrial DiseasesMadeleine Corkery-Hayward0Louise A. Metherell1Barts and the London Medical School, Queen Mary University of London, London E1 2AD, UKCentre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UKCortisol is central to several homeostatic mechanisms including the stress and immune response. Adrenal insufficiency and impaired cortisol production leads to severe, potentially fatal disorders. Several fundamental stages of steroidogenesis occur within the mitochondria. These dynamic organelles not only contribute ATP for steroidogenesis, but also detoxify harmful by-products generated during cortisol synthesis (reactive oxygen species). Mutations in nuclear or mitochondrial DNA that impair mitochondrial function lead to debilitating multi-system diseases. Recently, genetic variants that impair mitochondrial function have been identified in people with isolated cortisol insufficiency. This review aimed to clarify the association between mitochondrial diseases and adrenal insufficiency to produce cortisol. Mitochondrial diseases are rare and mitochondrial diseases that feature adrenal insufficiency are even rarer. We identified only 14 cases of adrenal insufficiency in people with confirmed mitochondrial diseases globally. In line with previous reviews, adrenal dysfunction was most prevalent in mitochondrial deletion syndromes (particularly Pearson syndrome and Kearns–Sayre syndrome) and with point mutations that compromised oxidative phosphorylation. Although adrenal insufficiency has been reported with mitochondrial diseases, the incidence reflects that expected in the general population. Thus, it is unlikely that mitochondrial mutations alone are responsible for an insufficiency to produce cortisol. More research is needed into the pathogenesis of adrenal disease in these individuals.https://www.mdpi.com/1422-0067/24/2/1126adrenal insufficiencymitochondriafamilial glucocorticoid deficiencymitochondrial diseases
spellingShingle Madeleine Corkery-Hayward
Louise A. Metherell
Adrenal Dysfunction in Mitochondrial Diseases
International Journal of Molecular Sciences
adrenal insufficiency
mitochondria
familial glucocorticoid deficiency
mitochondrial diseases
title Adrenal Dysfunction in Mitochondrial Diseases
title_full Adrenal Dysfunction in Mitochondrial Diseases
title_fullStr Adrenal Dysfunction in Mitochondrial Diseases
title_full_unstemmed Adrenal Dysfunction in Mitochondrial Diseases
title_short Adrenal Dysfunction in Mitochondrial Diseases
title_sort adrenal dysfunction in mitochondrial diseases
topic adrenal insufficiency
mitochondria
familial glucocorticoid deficiency
mitochondrial diseases
url https://www.mdpi.com/1422-0067/24/2/1126
work_keys_str_mv AT madeleinecorkeryhayward adrenaldysfunctioninmitochondrialdiseases
AT louiseametherell adrenaldysfunctioninmitochondrialdiseases